- Home
- MPX vs TSHA Comparison
MPX vs TSHA Comparison
Compare MPX & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPX
- TSHA
- Stock Information
- Founded
- MPX 1965
- TSHA 2019
- Country
- MPX United States
- TSHA United States
- Employees
- MPX N/A
- TSHA N/A
- Industry
- MPX Marine Transportation
- TSHA Biotechnology: Pharmaceutical Preparations
- Sector
- MPX Industrials
- TSHA Health Care
- Exchange
- MPX Nasdaq
- TSHA Nasdaq
- Market Cap
- MPX 326.0M
- TSHA 356.7M
- IPO Year
- MPX N/A
- TSHA 2020
- Fundamental
- Price
- MPX $8.18
- TSHA $1.66
- Analyst Decision
- MPX Hold
- TSHA Strong Buy
- Analyst Count
- MPX 1
- TSHA 8
- Target Price
- MPX $8.00
- TSHA $6.63
- AVG Volume (30 Days)
- MPX 27.5K
- TSHA 1.5M
- Earning Date
- MPX 04-24-2025
- TSHA 05-13-2025
- Dividend Yield
- MPX 6.70%
- TSHA N/A
- EPS Growth
- MPX N/A
- TSHA N/A
- EPS
- MPX 0.50
- TSHA N/A
- Revenue
- MPX $236,555,000.00
- TSHA $8,333,000.00
- Revenue This Year
- MPX $3.97
- TSHA N/A
- Revenue Next Year
- MPX $13.02
- TSHA N/A
- P/E Ratio
- MPX $16.88
- TSHA N/A
- Revenue Growth
- MPX N/A
- TSHA N/A
- 52 Week Low
- MPX $8.22
- TSHA $1.19
- 52 Week High
- MPX $12.47
- TSHA $4.32
- Technical
- Relative Strength Index (RSI)
- MPX 34.04
- TSHA 46.82
- Support Level
- MPX $8.29
- TSHA $1.69
- Resistance Level
- MPX $8.48
- TSHA $1.87
- Average True Range (ATR)
- MPX 0.22
- TSHA 0.10
- MACD
- MPX -0.02
- TSHA 0.00
- Stochastic Oscillator
- MPX 0.00
- TSHA 30.00
About MPX Marine Products Corporation
Marine Products Corp is a manufacturer of fiberglass motorized boats distributed and marketed through its independent dealer network. The company's only operating segment is Powerboat Manufacturing Business. It operates in the Powerboat Manufacturing business segment through Nashville, Georgia, Valdosta, and Georgia. Its product offerings include Chaparral sterndrive, outboard pleasure boats and Robalo outboard sport fishing boats. The company offers its products to the family recreational markets through its Chaparral brand and to the sportfishing market through its Robalo brand.
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.